CureMatch Articles & News
LISBON, PORTUGAL – CureMatch is proud to announce that CureMatch Chief Technology Officer and co-founder, Igor Tsigelny, PhD was invited in November as a plenary speaker to the PCS 4th Annual Global Cancer Conference-2017 in Lisbon, Portugal. The international meeting focused on basic research and clinical cancer research. Presentations and discussions concerning top cancer killers […]
A recent article in HealthcareIT News (Precision medicine clinical decision support system bests oncologists at picking cancer treatment) describes how CureMatch’s clinical decision support platform was used to aid oncologists in the selection of immunotherapy for a 57-year old patient. It explains how a therapy was selected by CureMatch following four previous failed treatment lines, […]
CureMatch has been featured in GenomeWeb’s recent in-depth article, “CureMatch Building Genomic Therapy-Matching Business Focused on Drug Combinations.” The article discusses CureMatch’s innovative product, which guides oncologists in the selection of cancer drugs customized for individual patients based on genomics. The product considers more than 4.5 million different cancer treatment options, including combinations of drugs. […]
Cancer comes with its own terminology—hopefully over the course of a series of blog posts we will clarify some of these terms and concepts. Because, after all, how can one make an informed decision about cancer treatment options if one doesn’t understand the disease and the cancer mutations involved? What Is Cancer? First of all, […]
Despite the fact that pediatric cancer death rates have decreased and survival rates increased over the past decades as a result of major advances in cancer treatment, cancer continues to remain a leading cause of death among children. According to the National Cancer Institute, in 2017, an estimate of 10,270 new cases of pediatric cancer […]